カテゴリー： LP Information, 世界, 部品/材料

世界のペフィシチニブ市場予測 2023年-2029年

◆英語タイトル：Global Peficitinib Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU6220）◆商品コード：LP23JU6220
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：105
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のペフィシチニブ市場」は、過去の販売実績から2022年の世界のペフィシチニブの総販売量を検討し、2023年から2029年の予測されるペフィシチニブの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のペフィシチニブの市場規模を掲載し、XXX百万米ドル規模の世界のペフィシチニブ市場の詳細な分析を提供します。本インサイトレポートは、世界のペフィシチニブ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のペフィシチニブ市場における各社の独自のポジションをより深く理解するために、ペフィシチニブ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のペフィシチニブ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ペフィシチニブの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ペフィシチニブの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ペフィシチニブのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ペフィシチニブの世界主要メーカーとしては、Cayman Chemical、 Adooq Bioscience、 BioVision、 Biorbyt、 MyBiosource、 AbMole、 Taiclone、 Selleck Chemicals、 BOC Sciences、 Wuhan Sun-shine Bio-technology、 MedKoo Biosciencesなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のペフィシチニブ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではペフィシチニブ市場をセグメンテーションし、種類別 (最小純度98%以下、最小純度98%-99%、最小純度99%以上)、用途別 (研究、医療)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：最小純度98%以下、最小純度98%-99%、最小純度99%以上

・用途別区分：研究、医療

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のペフィシチニブ市場の10年間の市場状況・展望は？
・世界および地域別に見たペフィシチニブ市場成長の要因は何か？
・ペフィシチニブの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ペフィシチニブのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ペフィシチニブの年間販売量2018-2029、地域別現状・将来分析
・ペフィシチニブの種類別セグメント：最小純度98%以下、最小純度98%-99%、最小純度99%以上
・ペフィシチニブの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ペフィシチニブの用途別セグメント：研究、医療
・ペフィシチニブの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のペフィシチニブ市場
・企業別のグローバルペフィシチニブ市場データ：2018-2023年の年間販売量、市場シェア
・企業別のペフィシチニブの年間売上：2018-2023年の売上、市場シェア
・企業別のペフィシチニブ販売価格
・主要企業のペフィシチニブ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ペフィシチニブの地域別レビュー
・地域別のペフィシチニブ市場規模2018-2023：年間販売量、売上
・主要国別のペフィシチニブ市場規模2018-2023：年間販売量、売上
・南北アメリカのペフィシチニブ販売の成長
・アジア太平洋のペフィシチニブ販売の成長
・ヨーロッパのペフィシチニブ販売の成長
・中東・アフリカのペフィシチニブ販売の成長

南北アメリカ市場
・南北アメリカの国別のペフィシチニブ販売量、売上（2018-2023）
・南北アメリカのペフィシチニブの種類別販売量
・南北アメリカのペフィシチニブの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のペフィシチニブ販売量、売上（2018-2023）
・アジア太平洋のペフィシチニブの種類別販売量
・アジア太平洋のペフィシチニブの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のペフィシチニブ販売量、売上（2018-2023）
・ヨーロッパのペフィシチニブの種類別販売量
・ヨーロッパのペフィシチニブの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のペフィシチニブ販売量、売上（2018-2023）
・中東・アフリカのペフィシチニブの種類別販売量
・中東・アフリカのペフィシチニブの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ペフィシチニブの製造コスト構造分析
・ペフィシチニブの製造プロセス分析
・ペフィシチニブの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ペフィシチニブの主要なグローバル販売業者
・ペフィシチニブの主要なグローバル顧客

地域別のペフィシチニブ市場予測レビュー
・地域別のペフィシチニブ市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ペフィシチニブの種類別市場規模予測
・ペフィシチニブの用途別市場規模予測

主要企業分析
Cayman Chemical、 Adooq Bioscience、 BioVision、 Biorbyt、 MyBiosource、 AbMole、 Taiclone、 Selleck Chemicals、 BOC Sciences、 Wuhan Sun-shine Bio-technology、 MedKoo Biosciences
・企業情報
・ペフィシチニブ製品
・ペフィシチニブ販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats.
LPI (LP Information)’ newest research report, the “Peficitinib Industry Forecast” looks at past sales and reviews total world Peficitinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Peficitinib sales for 2023 through 2029. With Peficitinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peficitinib industry.
This Insight Report provides a comprehensive analysis of the global Peficitinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peficitinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peficitinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peficitinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peficitinib.
The global Peficitinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Peficitinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peficitinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peficitinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peficitinib players cover Cayman Chemical, Adooq Bioscience, BioVision, Biorbyt, MyBiosource, AbMole, Taiclone, Selleck Chemicals and BOC Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peficitinib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Medical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Cayman Chemical
Adooq Bioscience
BioVision
Biorbyt
MyBiosource
AbMole
Taiclone
Selleck Chemicals
BOC Sciences
Wuhan Sun-shine Bio-technology
MedKoo Biosciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Peficitinib market?
What factors are driving Peficitinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peficitinib market opportunities vary by end market size?
How does Peficitinib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peficitinib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Peficitinib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Peficitinib by Country/Region, 2018, 2022 & 2029
2.2 Peficitinib Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Peficitinib Sales by Type
2.3.1 Global Peficitinib Sales Market Share by Type (2018-2023)
2.3.2 Global Peficitinib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Peficitinib Sale Price by Type (2018-2023)
2.4 Peficitinib Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Peficitinib Sales by Application
2.5.1 Global Peficitinib Sale Market Share by Application (2018-2023)
2.5.2 Global Peficitinib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Peficitinib Sale Price by Application (2018-2023)
3 Global Peficitinib by Company
3.1 Global Peficitinib Breakdown Data by Company
3.1.1 Global Peficitinib Annual Sales by Company (2018-2023)
3.1.2 Global Peficitinib Sales Market Share by Company (2018-2023)
3.2 Global Peficitinib Annual Revenue by Company (2018-2023)
3.2.1 Global Peficitinib Revenue by Company (2018-2023)
3.2.2 Global Peficitinib Revenue Market Share by Company (2018-2023)
3.3 Global Peficitinib Sale Price by Company
3.4 Key Manufacturers Peficitinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peficitinib Product Location Distribution
3.4.2 Players Peficitinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Peficitinib by Geographic Region
4.1 World Historic Peficitinib Market Size by Geographic Region (2018-2023)
4.1.1 Global Peficitinib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Peficitinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Peficitinib Market Size by Country/Region (2018-2023)
4.2.1 Global Peficitinib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Peficitinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Peficitinib Sales Growth
4.4 APAC Peficitinib Sales Growth
4.5 Europe Peficitinib Sales Growth
4.6 Middle East & Africa Peficitinib Sales Growth
5 Americas
5.1 Americas Peficitinib Sales by Country
5.1.1 Americas Peficitinib Sales by Country (2018-2023)
5.1.2 Americas Peficitinib Revenue by Country (2018-2023)
5.2 Americas Peficitinib Sales by Type
5.3 Americas Peficitinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peficitinib Sales by Region
6.1.1 APAC Peficitinib Sales by Region (2018-2023)
6.1.2 APAC Peficitinib Revenue by Region (2018-2023)
6.2 APAC Peficitinib Sales by Type
6.3 APAC Peficitinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Peficitinib by Country
7.1.1 Europe Peficitinib Sales by Country (2018-2023)
7.1.2 Europe Peficitinib Revenue by Country (2018-2023)
7.2 Europe Peficitinib Sales by Type
7.3 Europe Peficitinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peficitinib by Country
8.1.1 Middle East & Africa Peficitinib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Peficitinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Peficitinib Sales by Type
8.3 Middle East & Africa Peficitinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peficitinib
10.3 Manufacturing Process Analysis of Peficitinib
10.4 Industry Chain Structure of Peficitinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peficitinib Distributors
11.3 Peficitinib Customer
12 World Forecast Review for Peficitinib by Geographic Region
12.1 Global Peficitinib Market Size Forecast by Region
12.1.1 Global Peficitinib Forecast by Region (2024-2029)
12.1.2 Global Peficitinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peficitinib Forecast by Type
12.7 Global Peficitinib Forecast by Application
13 Key Players Analysis
13.1 Cayman Chemical
13.1.1 Cayman Chemical Company Information
13.1.2 Cayman Chemical Peficitinib Product Portfolios and Specifications
13.1.3 Cayman Chemical Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Cayman Chemical Main Business Overview
13.1.5 Cayman Chemical Latest Developments
13.2 Adooq Bioscience
13.2.1 Adooq Bioscience Company Information
13.2.2 Adooq Bioscience Peficitinib Product Portfolios and Specifications
13.2.3 Adooq Bioscience Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Adooq Bioscience Main Business Overview
13.2.5 Adooq Bioscience Latest Developments
13.3 BioVision
13.3.1 BioVision Company Information
13.3.2 BioVision Peficitinib Product Portfolios and Specifications
13.3.3 BioVision Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BioVision Main Business Overview
13.3.5 BioVision Latest Developments
13.4 Biorbyt
13.4.1 Biorbyt Company Information
13.4.2 Biorbyt Peficitinib Product Portfolios and Specifications
13.4.3 Biorbyt Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Biorbyt Main Business Overview
13.4.5 Biorbyt Latest Developments
13.5 MyBiosource
13.5.1 MyBiosource Company Information
13.5.2 MyBiosource Peficitinib Product Portfolios and Specifications
13.5.3 MyBiosource Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MyBiosource Main Business Overview
13.5.5 MyBiosource Latest Developments
13.6 AbMole
13.6.1 AbMole Company Information
13.6.2 AbMole Peficitinib Product Portfolios and Specifications
13.6.3 AbMole Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AbMole Main Business Overview
13.6.5 AbMole Latest Developments
13.7 Taiclone
13.7.1 Taiclone Company Information
13.7.2 Taiclone Peficitinib Product Portfolios and Specifications
13.7.3 Taiclone Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Taiclone Main Business Overview
13.7.5 Taiclone Latest Developments
13.8 Selleck Chemicals
13.8.1 Selleck Chemicals Company Information
13.8.2 Selleck Chemicals Peficitinib Product Portfolios and Specifications
13.8.3 Selleck Chemicals Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Selleck Chemicals Main Business Overview
13.8.5 Selleck Chemicals Latest Developments
13.9 BOC Sciences
13.9.1 BOC Sciences Company Information
13.9.2 BOC Sciences Peficitinib Product Portfolios and Specifications
13.9.3 BOC Sciences Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BOC Sciences Main Business Overview
13.9.5 BOC Sciences Latest Developments
13.10 Wuhan Sun-shine Bio-technology
13.10.1 Wuhan Sun-shine Bio-technology Company Information
13.10.2 Wuhan Sun-shine Bio-technology Peficitinib Product Portfolios and Specifications
13.10.3 Wuhan Sun-shine Bio-technology Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wuhan Sun-shine Bio-technology Main Business Overview
13.10.5 Wuhan Sun-shine Bio-technology Latest Developments
13.11 MedKoo Biosciences
13.11.1 MedKoo Biosciences Company Information
13.11.2 MedKoo Biosciences Peficitinib Product Portfolios and Specifications
13.11.3 MedKoo Biosciences Peficitinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 MedKoo Biosciences Main Business Overview
13.11.5 MedKoo Biosciences Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Peficitinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Peficitinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Peficitinib Sales by Type (2018-2023) & (Kg)
Table 7. Global Peficitinib Sales Market Share by Type (2018-2023)
Table 8. Global Peficitinib Revenue by Type (2018-2023) & ($ million)
Table 9. Global Peficitinib Revenue Market Share by Type (2018-2023)
Table 10. Global Peficitinib Sale Price by Type (2018-2023) & (K USD/Kg)
Table 11. Global Peficitinib Sales by Application (2018-2023) & (Kg)
Table 12. Global Peficitinib Sales Market Share by Application (2018-2023)
Table 13. Global Peficitinib Revenue by Application (2018-2023)
Table 14. Global Peficitinib Revenue Market Share by Application (2018-2023)
Table 15. Global Peficitinib Sale Price by Application (2018-2023) & (K USD/Kg)
Table 16. Global Peficitinib Sales by Company (2018-2023) & (Kg)
Table 17. Global Peficitinib Sales Market Share by Company (2018-2023)
Table 18. Global Peficitinib Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Peficitinib Revenue Market Share by Company (2018-2023)
Table 20. Global Peficitinib Sale Price by Company (2018-2023) & (K USD/Kg)
Table 21. Key Manufacturers Peficitinib Producing Area Distribution and Sales Area
Table 22. Players Peficitinib Products Offered
Table 23. Peficitinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Peficitinib Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Peficitinib Sales Market Share Geographic Region (2018-2023)
Table 28. Global Peficitinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Peficitinib Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Peficitinib Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Peficitinib Sales Market Share by Country/Region (2018-2023)
Table 32. Global Peficitinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Peficitinib Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Peficitinib Sales by Country (2018-2023) & (Kg)
Table 35. Americas Peficitinib Sales Market Share by Country (2018-2023)
Table 36. Americas Peficitinib Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Peficitinib Revenue Market Share by Country (2018-2023)
Table 38. Americas Peficitinib Sales by Type (2018-2023) & (Kg)
Table 39. Americas Peficitinib Sales by Application (2018-2023) & (Kg)
Table 40. APAC Peficitinib Sales by Region (2018-2023) & (Kg)
Table 41. APAC Peficitinib Sales Market Share by Region (2018-2023)
Table 42. APAC Peficitinib Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Peficitinib Revenue Market Share by Region (2018-2023)
Table 44. APAC Peficitinib Sales by Type (2018-2023) & (Kg)
Table 45. APAC Peficitinib Sales by Application (2018-2023) & (Kg)
Table 46. Europe Peficitinib Sales by Country (2018-2023) & (Kg)
Table 47. Europe Peficitinib Sales Market Share by Country (2018-2023)
Table 48. Europe Peficitinib Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Peficitinib Revenue Market Share by Country (2018-2023)
Table 50. Europe Peficitinib Sales by Type (2018-2023) & (Kg)
Table 51. Europe Peficitinib Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Peficitinib Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Peficitinib Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Peficitinib Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Peficitinib Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Peficitinib Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Peficitinib Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Peficitinib
Table 59. Key Market Challenges & Risks of Peficitinib
Table 60. Key Industry Trends of Peficitinib
Table 61. Peficitinib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Peficitinib Distributors List
Table 64. Peficitinib Customer List
Table 65. Global Peficitinib Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Peficitinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Peficitinib Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Peficitinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Peficitinib Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Peficitinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Peficitinib Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Peficitinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Peficitinib Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Peficitinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Peficitinib Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Peficitinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Peficitinib Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Peficitinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Cayman Chemical Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 80. Cayman Chemical Peficitinib Product Portfolios and Specifications
Table 81. Cayman Chemical Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 82. Cayman Chemical Main Business
Table 83. Cayman Chemical Latest Developments
Table 84. Adooq Bioscience Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 85. Adooq Bioscience Peficitinib Product Portfolios and Specifications
Table 86. Adooq Bioscience Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 87. Adooq Bioscience Main Business
Table 88. Adooq Bioscience Latest Developments
Table 89. BioVision Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 90. BioVision Peficitinib Product Portfolios and Specifications
Table 91. BioVision Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 92. BioVision Main Business
Table 93. BioVision Latest Developments
Table 94. Biorbyt Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 95. Biorbyt Peficitinib Product Portfolios and Specifications
Table 96. Biorbyt Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 97. Biorbyt Main Business
Table 98. Biorbyt Latest Developments
Table 99. MyBiosource Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 100. MyBiosource Peficitinib Product Portfolios and Specifications
Table 101. MyBiosource Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 102. MyBiosource Main Business
Table 103. MyBiosource Latest Developments
Table 104. AbMole Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 105. AbMole Peficitinib Product Portfolios and Specifications
Table 106. AbMole Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 107. AbMole Main Business
Table 108. AbMole Latest Developments
Table 109. Taiclone Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 110. Taiclone Peficitinib Product Portfolios and Specifications
Table 111. Taiclone Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 112. Taiclone Main Business
Table 113. Taiclone Latest Developments
Table 114. Selleck Chemicals Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 115. Selleck Chemicals Peficitinib Product Portfolios and Specifications
Table 116. Selleck Chemicals Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 117. Selleck Chemicals Main Business
Table 118. Selleck Chemicals Latest Developments
Table 119. BOC Sciences Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 120. BOC Sciences Peficitinib Product Portfolios and Specifications
Table 121. BOC Sciences Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 122. BOC Sciences Main Business
Table 123. BOC Sciences Latest Developments
Table 124. Wuhan Sun-shine Bio-technology Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 125. Wuhan Sun-shine Bio-technology Peficitinib Product Portfolios and Specifications
Table 126. Wuhan Sun-shine Bio-technology Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 127. Wuhan Sun-shine Bio-technology Main Business
Table 128. Wuhan Sun-shine Bio-technology Latest Developments
Table 129. MedKoo Biosciences Basic Information, Peficitinib Manufacturing Base, Sales Area and Its Competitors
Table 130. MedKoo Biosciences Peficitinib Product Portfolios and Specifications
Table 131. MedKoo Biosciences Peficitinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 132. MedKoo Biosciences Main Business
Table 133. MedKoo Biosciences Latest Developments
List of Figures
Figure 1. Picture of Peficitinib
Figure 2. Peficitinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peficitinib Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Peficitinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Peficitinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Peficitinib Sales Market Share by Type in 2022
Figure 13. Global Peficitinib Revenue Market Share by Type (2018-2023)
Figure 14. Peficitinib Consumed in Research
Figure 15. Global Peficitinib Market: Research (2018-2023) & (Kg)
Figure 16. Peficitinib Consumed in Medical
Figure 17. Global Peficitinib Market: Medical (2018-2023) & (Kg)
Figure 18. Global Peficitinib Sales Market Share by Application (2022)
Figure 19. Global Peficitinib Revenue Market Share by Application in 2022
Figure 20. Peficitinib Sales Market by Company in 2022 (Kg)
Figure 21. Global Peficitinib Sales Market Share by Company in 2022
Figure 22. Peficitinib Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Peficitinib Revenue Market Share by Company in 2022
Figure 24. Global Peficitinib Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Peficitinib Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Peficitinib Sales 2018-2023 (Kg)
Figure 27. Americas Peficitinib Revenue 2018-2023 ($ Millions)
Figure 28. APAC Peficitinib Sales 2018-2023 (Kg)
Figure 29. APAC Peficitinib Revenue 2018-2023 ($ Millions)
Figure 30. Europe Peficitinib Sales 2018-2023 (Kg)
Figure 31. Europe Peficitinib Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Peficitinib Sales 2018-2023 (Kg)
Figure 33. Middle East & Africa Peficitinib Revenue 2018-2023 ($ Millions)
Figure 34. Americas Peficitinib Sales Market Share by Country in 2022
Figure 35. Americas Peficitinib Revenue Market Share by Country in 2022
Figure 36. Americas Peficitinib Sales Market Share by Type (2018-2023)
Figure 37. Americas Peficitinib Sales Market Share by Application (2018-2023)
Figure 38. United States Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Peficitinib Sales Market Share by Region in 2022
Figure 43. APAC Peficitinib Revenue Market Share by Regions in 2022
Figure 44. APAC Peficitinib Sales Market Share by Type (2018-2023)
Figure 45. APAC Peficitinib Sales Market Share by Application (2018-2023)
Figure 46. China Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Peficitinib Sales Market Share by Country in 2022
Figure 54. Europe Peficitinib Revenue Market Share by Country in 2022
Figure 55. Europe Peficitinib Sales Market Share by Type (2018-2023)
Figure 56. Europe Peficitinib Sales Market Share by Application (2018-2023)
Figure 57. Germany Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Peficitinib Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Peficitinib Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Peficitinib Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Peficitinib Sales Market Share by Application (2018-2023)
Figure 66. Egypt Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Peficitinib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Peficitinib in 2022
Figure 72. Manufacturing Process Analysis of Peficitinib
Figure 73. Industry Chain Structure of Peficitinib
Figure 74. Channels of Distribution
Figure 75. Global Peficitinib Sales Market Forecast by Region (2024-2029)
Figure 76. Global Peficitinib Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Peficitinib Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Peficitinib Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Peficitinib Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Peficitinib Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のペフィシチニブ市場予測 2023年-2029年(Global Peficitinib Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のHi-Fiワイヤー市場予測 2023年-2029年
  • 世界のPC&ABS樹脂市場予測 2023年-2029年
  • 世界の爆竹市場予測 2023年-2029年
  • 世界のPVC床材市場予測 2023年-2029年
  • 世界の家具用ヒンジ市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆